meta_study_length

This is information on the duration of CTN-0094 trial periods.

datasets

These are harmonized datasets produced as part of the Clinical
Trials Network (CTN) protocol number 0094. This is a US National Institute
of Drug Abuse (NIDA) funded project; to learn more go to
<https://ctnlibrary.org/protocol/ctn0094/>. These are datasets which have
the data harmonized from CTN-0027 (<https://ctnlibrary.org/protocol/ctn0027/>),
CTN-0030 (<https://ctnlibrary.org/protocol/ctn0030/>), and CTN-0051
(<https://ctnlibrary.org/protocol/ctn0051/>).

Raymond Balise

public.ctn0094data

De-Identified Data from CTN-0094

Gabriel Odom

Anna Calderon

Kyle Grealis

Michael Ackerman

meta_study_length function

A tibble with 16 rows and
6 variables:
<dl>
<dt>project</dt>
<dd><table class="table">
<tr><td>Type:</td><td>factor (First/Reference level = 27)</td></tr>
<tr><td></td><td></td></tr>
<tr><td>Description:</td><td>CTN project number</td></tr>
<tr><td></td><td></td></tr>
<tr><td>Levels:</td><td>27, 30, 51</td></tr>
</table></dd><dt>treatment</dt>
<dd><table class="table">
<tr><td>Type:</td><td>factor (First/Reference level = Inpatient BUP)</td></tr>
<tr><td></td><td></td></tr>
<tr><td>Description:</td><td><ul><li>ctn_0027:<ul><li>Methadone</li><li>Outpatient BUP</li></ul></li><li>ctn_0030: <ul><li>Outpatient BUP + EMM</li><li>Outpatient BUP + SMM</li></ul></li><li>ctn_0051: <ul><li>Outpatient BUP + EMM</li><li>Outpatient BUP + SMM</li></ul></li></ul></td></tr>
<tr><td></td><td></td></tr>
<tr><td>Levels:</td><td>Inpatient BUP, Inpatient NR-NTX, Methadone, Outpatient BUP, Outpatient BUP + EMM, Outpatient BUP + SMM</td></tr>
</table></dd><dt>phase</dt>
<dd><table class="table">
<tr><td>Type:</td><td>factor (First/Reference level = 1)</td></tr>
<tr><td></td><td></td></tr>
<tr><td>Description:</td><td>Study phase (needed because of CTN 30)</td></tr>
<tr><td></td><td></td></tr>
<tr><td>Levels:</td><td>1, 2</td></tr>
</table></dd><dt>stage</dt>
<dd><table class="table">
<tr><td>Type:</td><td>factor (First/Reference level = 1)</td></tr>
<tr><td></td><td></td></tr>
<tr><td>Description:</td><td>Treatment stage used with <code>description</code> to capture different treatment phase/stage/period</td></tr>
<tr><td></td><td></td></tr>
<tr><td>Levels:</td><td>1, 2, 3</td></tr>
</table></dd><dt>weeks</dt>
<dd><table class="table">
<tr><td>Type:</td><td>integer</td></tr>
<tr><td></td><td></td></tr>
<tr><td>Description:</td><td>Treatment duration in weeks</td></tr>
</table></dd><dt>description</dt>
<dd><table class="table">
<tr><td>Type:</td><td>factor (First/Reference level = Buprenorphine-naloxone stabilization)</td></tr>
<tr><td></td><td></td></tr>
<tr><td>Description:</td><td>Description of the treatment duration</td></tr>
<tr><td></td><td></td></tr>
<tr><td>Levels:</td><td>Buprenorphine-naloxone stabilization, Buprenorphine-naloxone treatment, Post-medication follow-up, Taper, Treatment</td></tr>
</table></dd>
</dl>

Format

Metadata About Study Length — meta_study_length

A tibble with 16 rows and
6 variables:
<dl>
<dt>project</dt>
<dd><table class='table'>
<tr><td>Type:</td><td>factor (First/Reference level = 27)</td></tr>
<tr><td></td><td></td></tr>
<tr><td>Description:</td><td>CTN project number</td></tr>
<tr><td></td><td></td></tr>
<tr><td>Levels:</td><td>27, 30, 51</td></tr>
</table>



</dd>

<dt>treatment</dt>
<dd><table class='table'>
<tr><td>Type:</td><td>factor (First/Reference level = Inpatient BUP)</td></tr>
<tr><td></td><td></td></tr>
<tr><td>Description:</td><td><ul><li>ctn_0027:<ul><li>Methadone</li><li>Outpatient BUP</li></ul></li><li>ctn_0030: <ul><li>Outpatient BUP + EMM</li><li>Outpatient BUP + SMM</li></ul></li><li>ctn_0051: <ul><li>Outpatient BUP + EMM</li><li>Outpatient BUP + SMM</li></ul></li></ul></td></tr>
<tr><td></td><td></td></tr>
<tr><td>Levels:</td><td>Inpatient BUP, Inpatient NR-NTX, Methadone, Outpatient BUP, Outpatient BUP + EMM, Outpatient BUP + SMM</td></tr>
</table>



</dd>

<dt>phase</dt>
<dd><table class='table'>
<tr><td>Type:</td><td>factor (First/Reference level = 1)</td></tr>
<tr><td></td><td></td></tr>
<tr><td>Description:</td><td>Study phase (needed because of CTN 30)</td></tr>
<tr><td></td><td></td></tr>
<tr><td>Levels:</td><td>1, 2</td></tr>
</table>



</dd>

<dt>stage</dt>
<dd><table class='table'>
<tr><td>Type:</td><td>factor (First/Reference level = 1)</td></tr>
<tr><td></td><td></td></tr>
<tr><td>Description:</td><td>Treatment stage used with <code>description</code> to capture different treatment phase/stage/period</td></tr>
<tr><td></td><td></td></tr>
<tr><td>Levels:</td><td>1, 2, 3</td></tr>
</table>



</dd>

<dt>weeks</dt>
<dd><table class='table'>
<tr><td>Type:</td><td>integer</td></tr>
<tr><td></td><td></td></tr>
<tr><td>Description:</td><td>Treatment duration in weeks</td></tr>
</table>



</dd>

<dt>description</dt>
<dd><table class='table'>
<tr><td>Type:</td><td>factor (First/Reference level = Buprenorphine-naloxone stabilization)</td></tr>
<tr><td></td><td></td></tr>
<tr><td>Description:</td><td>Description of the treatment duration</td></tr>
<tr><td></td><td></td></tr>
<tr><td>Levels:</td><td>Buprenorphine-naloxone stabilization, Buprenorphine-naloxone treatment, Post-medication follow-up, Taper, Treatment</td></tr>
</table>



</dd>


</dl>

Type:	factor (First/Reference level = Inpatient BUP)

Description:	ctn_0027: Methadone Outpatient BUP ctn_0030: Outpatient BUP + EMM Outpatient BUP + SMM ctn_0051: Outpatient BUP + EMM Outpatient BUP + SMM

Levels:	Inpatient BUP, Inpatient NR-NTX, Methadone, Outpatient BUP, Outpatient BUP + EMM, Outpatient BUP + SMM

Type:	factor (First/Reference level = 1)

Description:	Treatment stage used with `description` to capture different treatment phase/stage/period

Levels:	1, 2, 3

meta_study_length: Metadata About Study Length

Description

Usage

Arguments

Format

Type:	factor (First/Reference level = 27)

Description:	CTN project number

Levels:	27, 30, 51

Type:	factor (First/Reference level = Buprenorphine-naloxone stabilization)

Description:	Description of the treatment duration

Levels:	Buprenorphine-naloxone stabilization, Buprenorphine-naloxone treatment, Post-medication follow-up, Taper, Treatment